What is Repotrectinib: Uses, Dosage, Side Effects and More

Repotrectinib is a targeted cancer medication that works by blocking specific proteins that help cancer cells grow and spread. This oral medication belongs to a class of drugs called kinase inhibitors, which means it interrupts the signals that tell cancer cells to multiply.

Your doctor might prescribe repotrectinib when other cancer treatments haven't worked as well as hoped. It represents a newer approach to cancer treatment that focuses on the specific genetic changes driving your particular cancer.

What is Repotrectinib Used For?

Repotrectinib is specifically designed to treat certain types of non-small cell lung cancer (NSCLC) that have particular genetic changes. Your cancer cells need to have what doctors call ROS1 or NTRK gene fusions for this medication to work effectively.

This medication is typically prescribed when you've already tried other targeted therapies that didn't work or stopped working. Your doctor will run special tests on your cancer tissue to confirm that repotrectinib is the right choice for your specific situation.

In some cases, doctors might also consider repotrectinib for other solid tumors that have NTRK gene fusions, though this is less common. Your oncologist will discuss whether your particular cancer type and genetic makeup make you a good candidate for this treatment.

How Does Repotrectinib Work?

Repotrectinib works by targeting and blocking specific proteins called kinases that act like switches inside cancer cells. When these switches are turned on, they tell cancer cells to grow, divide, and spread throughout your body.

Think of it like cutting the power lines to a factory - when repotrectinib blocks these protein switches, the cancer cells can't receive the signals they need to keep growing. This helps slow down or stop the cancer from spreading to other parts of your body.

As a targeted therapy, repotrectinib is considered quite potent for the specific genetic types of cancer it treats. However, it's designed to be more precise than traditional chemotherapy, focusing mainly on cancer cells rather than affecting all rapidly dividing cells in your body.

How Should I Take Repotrectinib?

You'll take repotrectinib by mouth, usually once daily with or without food. Your doctor will start you on a specific dose based on your individual situation, and it's important to take it at the same time each day to maintain steady levels in your body.

Swallow the capsules whole with a full glass of water - don't crush, chew, or open them. If you have trouble swallowing capsules, talk to your healthcare team about strategies that might help, but never alter the capsules themselves.

You can take repotrectinib with meals or on an empty stomach, whichever feels more comfortable for you. Some people find that taking it with food helps reduce stomach upset, while others prefer taking it on an empty stomach for better absorption.

If you vomit shortly after taking your dose, don't take an extra dose that day. Simply continue with your regular schedule the next day and let your doctor know what happened.

How Long Should I Take Repotrectinib For?

You'll typically continue taking repotrectinib as long as it's helping control your cancer and you're tolerating it well. Unlike some medications that you take for a specific number of days or weeks, cancer treatments often continue for months or even years.

Your doctor will monitor your response through regular scans and blood tests to see how well the medication is working. If your cancer starts growing again or if you develop side effects that are too difficult to manage, your doctor might adjust your dose or switch to a different treatment.

Some people take repotrectinib for many months with good results, while others might need to stop sooner due to side effects or changes in their cancer. Your treatment timeline will be unique to your situation and how your body responds to the medication.

What Are the Side Effects of Repotrectinib?

Like all cancer medications, repotrectinib can cause side effects, though not everyone experiences them. The most common side effects are generally manageable with proper monitoring and supportive care from your healthcare team.

Here are the side effects you might experience, starting with the most common ones:

• Fatigue and feeling more tired than usual
• Nausea and changes in appetite
• Diarrhea or changes in bowel movements
• Dizziness or feeling lightheaded
• Changes in taste (foods might taste different)
• Swelling in your hands, feet, or legs
• Muscle or joint pain
• Headaches

These common side effects are usually mild to moderate and often improve as your body adjusts to the medication. Your healthcare team can suggest ways to manage these symptoms and help you feel more comfortable.

Some people may experience more serious side effects that require immediate medical attention. While these are less common, it's important to be aware of them:

• Severe breathing problems or shortness of breath
• Chest pain or irregular heartbeat
• Signs of liver problems (yellowing of skin or eyes, dark urine, severe stomach pain)
• Severe dizziness or fainting
• Signs of infection (fever, chills, persistent cough)
• Unusual bleeding or bruising

If you experience any of these serious symptoms, contact your healthcare provider immediately or seek emergency medical care. Your safety is the top priority, and your medical team is there to help you through any challenges.

Who Should Not Take Repotrectinib?

Repotrectinib isn't suitable for everyone, and your doctor will carefully review your medical history before prescribing it. Certain health conditions or medications can make repotrectinib less safe or effective for you.

You should discuss these factors with your healthcare team before starting treatment:

• Severe liver disease or liver function problems
• Heart rhythm disorders or significant heart disease
• Current pregnancy or plans to become pregnant
• Breastfeeding or plans to breastfeed
• Severe kidney disease
• Taking certain medications that interact with repotrectinib

If you're of childbearing age, your doctor will discuss effective birth control methods since repotrectinib can harm a developing baby. Both men and women should use reliable contraception during treatment and for several months after stopping the medication.

Your doctor will also review all your current medications, including over-the-counter drugs and supplements, to check for potential interactions. Some medications can affect how repotrectinib works or increase your risk of side effects.

Repotrectinib Brand Names

Repotrectinib is available under the brand name Augtyro. This is the commercial name you'll see on your prescription bottle and medication packaging.

Since repotrectinib is a newer medication, it's currently only available as the brand-name version. Generic versions may become available in the future, but for now, Augtyro is the only form of repotrectinib on the market.

When discussing your treatment with healthcare providers or insurance companies, they might refer to either the generic name (repotrectinib) or the brand name (Augtyro), but they're the same medication.

Repotrectinib Alternatives

If repotrectinib isn't the right fit for you, several other targeted therapies might be options depending on your cancer's genetic makeup. Your oncologist will help determine which alternatives might work best for your specific situation.

For ROS1-positive lung cancers, other targeted therapies include:

• Crizotinib (Xalkori) - often used as a first-line treatment
• Ceritinib (Zykadia) - another option for ROS1-positive cancers
• Entrectinib (Rozlytrek) - works for both ROS1 and NTRK fusions

For NTRK fusion-positive cancers, entrectinib (Rozlytrek) is another targeted option that works similarly to repotrectinib. Your doctor might also consider immunotherapy or traditional chemotherapy depending on your overall health and treatment history.

The choice between these alternatives depends on factors like your previous treatments, overall health, side effect tolerance, and how your cancer has responded to other therapies. Your oncologist will work with you to find the most appropriate treatment plan.

Is Repotrectinib Better Than Crizotinib?

Repotrectinib and crizotinib both treat ROS1-positive lung cancers, but they work somewhat differently and are typically used at different stages of treatment. Crizotinib is often used as the first targeted therapy, while repotrectinib is usually reserved for when other treatments have stopped working.

Research suggests that repotrectinib may be more effective for cancers that have developed resistance to crizotinib. This means if your cancer has grown despite crizotinib treatment, repotrectinib might be a better option for you.

Repotrectinib is also designed to work better against cancer that has spread to the brain, which can be a significant advantage for some patients. However, both medications have their own side effect profiles and considerations.

Your doctor will consider your treatment history, current health status, and how your cancer has responded to previous therapies when deciding between these options. Neither medication is universally "better" - the best choice depends on your individual circumstances.